La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Apoptose »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Apomorphine < Apoptose < Appareil Golgi  Facettes :

List of bibliographic references indexed by Apoptose

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000B80 (2014) Alexandro Gianforcaro [Canada] ; Mazen J. Hamadeh [Canada]Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis
000B90 (2014) YOUN JU LEE [Corée du Sud] ; So-Young Choi [Corée du Sud] ; Jae H. Yang [Corée du Sud]NMDA receptor-mediated ERK 1/2 pathway is involved in PFHxS-induced apoptosis of PC12 cells
001332 (2012) Sandra Noble [Canada] ; Abid Ismail [Canada] ; Rafael Godoy [Canada] ; Yanwei Xi [Canada] ; Marc Ekker [Canada]Zebrafish Parla‐ and Parlb‐deficiency affects dopaminergic neuron patterning and embryonic survival
001486 (2012) K. Y. Chu [Canada] ; H. Li [Canada] ; K. Wada [Japon] ; J. D. Johnson [Canada]Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions
001B41 (2010) Tomoko Kanao ; Katerina Venderova ; David S. Park ; Terry Unterman ; Bingwei Lu [États-Unis] ; Yuzuru Imai [Japon]Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila
002089 (2009) Katrina Mcgonigal [Canada] ; Jamshid Tanha [Canada] ; Elitza Palazov [Canada] ; SHENGHUA LI [Canada] ; Deyzi Gueorguieva-Owens [Canada] ; Siyaram Pandey [Canada]Isolation and Functional Characterization of Single Domain Antibody Modulators of Caspase-3 and Apoptosis
002109 (2009) Sandra Lourenssen [Canada] ; Kurtis G. Miller [Canada] ; Michael G. Blennerhassett [Canada]Discrete responses of myenteric neurons to structural and functional damage by neurotoxins in vitro
002629 (2007) M. D. Norenberg [États-Unis] ; K. V. Rama Rao [États-Unis]The mitochondrial permeability transition in neurologic disease
002B12 (2005) V. F. Rafuse [Canada] ; P. Soundararajan [Canada] ; C. Leopold [Canada] ; H. A. Robertson [Canada]Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog
002D15 (2004) S. Mccarthy [Canada] ; M. Somayajulu [Canada] ; M. Sikorska [Canada] ; H. Borowy-Borowski [Canada] ; S. Pandey [Canada]Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10
002F35 (2003) ZHIGAO HUANG [Canada] ; Raul De La Fuente-Fernandez [Canada] ; A. Jon Stoessl [Canada]Etiology of Parkinson's disease
003275 (2001) Wakako Maruyama [Japon] ; Yukihiro Akao [Japon] ; Moussa B. H. Youdim [Israël] ; Bruce A. Davis [Canada] ; Makoto Naoi [Japon]Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol
003291 (2001) Andreas Hartmann [France] ; Etienne C. Hirsch [France]Parkinson's disease: The apoptosis hypothesis revisited
003328 (2001) W. Maruyama [Japon] ; A. A. Boulton [Canada] ; B. A. Davis [Canada] ; P. Dostert [France] ; M. Naoi [Japon]Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells : Suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine
003814 (1999) D. L. Gelowitz [États-Unis] ; I. A. Paterson [Canada]Neuronal sparing and behavioral effects of the antiapoptotic drug, (-)deprenyl, following kainic acid administration
003A39 (1998) FENGQINSI [Canada] ; G. M. Ross [Canada] ; S. H. Shin [Canada]Glutathione protects PC12 cells from ascorbate- and dopamine-induced apoptosis
003C55 (1997) N. A. Tatton [Canada] ; S. J. Kish [Canada]In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and Acridine Orange Staining
003E90 (1996) W. G. Tatton [Canada] ; R. M. E. Chalmers-Redman [Canada]Modulation of gene expression rather than monoamine oxidase inhibition : (-)-Deprenyl-related compounds in controlling neurodegeneration

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Apoptose" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Apoptose" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Apoptose
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022